Epidemiology and economic burden of nonmelanoma skin cancer.

The authors present a succinct summary of the incidence and costs of nonmelanoma skin cancers. They present incidence and health care costs for this disease from Australia, United States, and Europe, noting that NMSC care cost stands in fifth place after prostate, lung, colon, and breast carcinomas.

[1]  M. Chren,et al.  Patient Satisfaction After Treatment of Nonmelanoma Skin Cancer , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[2]  S. Feldman,et al.  The economic impact of non-melanoma skin cancer: a review. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  D. Ekwueme,et al.  Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer , 2011, PharmacoEconomics.

[4]  Steven R Feldman,et al.  Treatment Patterns and Cost of Nonmelanoma Skin Cancer Management , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[5]  G. Tinghög,et al.  Societal cost of skin cancer in Sweden in 2005. , 2008, Acta dermato-venereologica.

[6]  C. Hanke,et al.  Cost effectiveness of Mohs micrographic surgery: review of the literature. , 2009, Journal of drugs in dermatology : JDD.

[7]  Steven R Feldman,et al.  Skin cancer is among the most costly of all cancers to treat for the Medicare population. , 2003, Journal of the American Academy of Dermatology.

[8]  E. D. Smith,et al.  Cost of Nonmelanoma Skin Cancer Treatment in the United States , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[9]  Brett M. Coldiron,et al.  Incidence estimate of nonmelanoma skin cancer in the United States, 2006. , 2010, Archives of dermatology.

[10]  Graham G Giles,et al.  Non‐melanoma skin cancer in Australia: the 2002 national survey and trends since 1985 , 2006, The Medical journal of Australia.

[11]  T. H. Nguyen,et al.  Nonmelanoma skin cancer , 2002, Current treatment options in oncology.

[12]  P. Buettner,et al.  Multiple nonmelanoma skin cancer in an exposed Australian population , 2002, International journal of dermatology.

[13]  S. Arias-Santiago,et al.  [Changes in the incidence of skin cancer between 1978 and 2002]. , 2010, Actas dermo-sifiliograficas.

[14]  J. Leonardi-Bee,et al.  A systematic review of worldwide incidence of nonmelanoma skin cancer , 2012, The British journal of dermatology.

[15]  R. Stern,et al.  Prevalence of a history of skin cancer in 2007: results of an incidence-based model. , 2010, Archives of dermatology.

[16]  J. Stausberg,et al.  Nationwide hospitalization costs of skin melanoma and non‐melanoma skin cancer in Germany , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[17]  Swee T Tan,et al.  Non-melanoma skin cancers in New Zealand--a neglected problem. , 2010, The New Zealand medical journal.